Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy - Wikidata - awgldk - TriplyDB

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

http://www.wikidata.org/entity/Q36458146

about

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis Contemporary Management of Prostate Cancer Nomograms in oncology: more than meets the eye Emerging critical role of molecular testing in diagnostic genitourinary pathology Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer Adjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis.A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy Design of a Global Medical Database which is Searchable by Human Diagnostic Patterns Targeted nanoagents for the detection of cancers Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Hypermethylation of genes for diagnosis and risk stratification of prostate cancer The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI.Prediction models in urology: are they any good, and how would we know anyway?Challenges in clinical prostate cancer: role of imaging.Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.Critical review of prostate cancer predictive tools High-risk prostate cancer in the United States, 1990-2007 Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.Contemporary trends in low risk prostate cancer: risk assessment and treatment Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively Expression changes in the stroma of prostate cancer predict subsequent relapse Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?A multi-institutional evaluation of active surveillance for low risk prostate cancer.Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer.The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.Prostate volume has prognostic value only in pathologic T2 radical prostatectomy specimens.Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.Evaluation of prediction models for the staging of prostate cancer.Use of nomograms for predictions of outcome in patients with advanced bladder cancer.Two criteria for evaluating risk prediction models Prediction models in cancer care.Prostate cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.

P2860

Q24645292-62B2CEB3-E15D-4753-8DAF-222845EEC197 Q26767456-03F767F8-A768-4E63-A429-B29B03839CBF Q26830260-4541F4EB-8086-4957-939A-6D391FE6DB81 Q27021371-3A65528E-A33A-4DC7-ADCC-3DA0FF911B2A Q27853341-415DB2EE-607D-4F7E-99E0-DF3CB48B8B16 Q28533760-21F86FA0-9FC2-4F70-8841-8B483CF15740 Q28539777-D9738F4E-B1F4-4743-A5B4-18DE5EC91403 Q28541950-3527B5E9-4260-44C3-A38C-FE068C96276C Q28543958-FD62A7A6-8A2B-4EF5-B40C-D6A4BF55B0EA Q28754787-6297B080-1E33-401B-93FC-71EAF532A84E Q30472641-4EF91973-6AF5-4750-9287-DDADF5BAAC32 Q30504100-2DD60C48-8B36-47B2-B178-9C33481BE46E Q33410858-562435D6-BDBF-472B-B227-E47C2421C7DE Q33516060-4EFFD754-042E-41A6-AC12-3CEEA72F202A Q33772524-1B2410A7-6B1B-4729-B372-9C913D460D63 Q33852664-F8277C22-BF41-4CEA-83FC-A4FD7AEFFBFB Q33896203-747E9A0E-0723-42F3-8E58-28DCEE721532 Q33940082-99FBCB22-4919-4A77-8EF0-4CACC8F324CF Q33940100-0E86609A-26B4-4233-A16B-069A68AA128A Q33945133-497B7B10-FC73-495B-9B1B-6F773DE66C6E Q33993472-CDE11EA2-130A-4CF7-B117-65910267EB6E Q34104562-2FA1B816-0217-4630-920E-66B8BE314048 Q34168382-5CBB6827-8BC4-4730-A001-788270D7B869 Q34267902-4DCEE0D3-AC2B-4B48-A6C6-4A0C827465AE Q34330041-A43E1226-ED49-4E3D-9961-7E987B9D1417 Q34332454-6E87D7B8-CD95-4809-AC79-27ED2FAEC8E4 Q34368873-C8A2B5EF-5126-46DF-A3D4-3126856A5A2A Q34451219-DC1CE64D-0246-4D87-99E6-B44D837A180A Q34534796-B2A54380-3F64-4917-AC8C-2717055C8D92 Q34541484-B44A56B8-BB58-4E98-8923-8C18FC4E829E Q34689090-1C3DB038-02B1-4907-928A-393E2481CD1C Q34960819-B5BC224C-5E85-4BBA-97BE-C998AAB83BB1 Q35009882-FDD5B511-0422-44BC-875A-28F4F560EB8E Q35017805-30228633-D3B7-4200-9E22-A29213EF708B Q35041485-20D4E4B5-6DB9-444A-98A3-F81229BA0ADC Q35044520-52B7C9B5-0504-44DD-B817-25B3939BAA2F Q35076360-75DEDEA8-F30D-4AA7-9D4F-D8284726B453 Q35103714-C2972343-C3ED-4D48-97EF-8DC6B3368D69 Q35292878-32756758-547B-4250-9841-7BA878B325C6 Q35439944-5BDB2A93-FACE-4688-A57B-4AF8A78ADA90

P2860

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

http://www.wikidata.org/entity/Q36458146

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Preoperative nomogram predicti ...... ce after radical prostatectomy

@ast

Preoperative nomogram predicti ...... ce after radical prostatectomy

@en

type

label

Preoperative nomogram predicti ...... ce after radical prostatectomy

@ast

Preoperative nomogram predicti ...... ce after radical prostatectomy

@en

prefLabel

Preoperative nomogram predicti ...... ce after radical prostatectomy

@ast

Preoperative nomogram predicti ...... ce after radical prostatectomy

@en

P1433

Q36458146-622ED2D4-E12E-435E-8080-97F0FEEABDD1

P1476

Q36458146-FE7217FE-D84C-45FF-8FDF-F6F380CD18F2

P2093

Q36458146-4854FA98-538E-43DF-B050-B7C5E872E062

Q36458146-5BE19752-125B-461F-B0DC-CF0F46A8F1F9

Q36458146-73578369-A478-4970-A463-DE8FDA3E7BF9

Q36458146-9A02CC9D-CC2A-4BBE-B2B4-E1625B9081DF

Q36458146-B20E82E2-D10A-4C17-8416-521B57743D91

Q36458146-B85B7B69-FD9E-496A-BF64-072912EF2E4B

Q36458146-FCD604C6-5334-4872-8A6B-99C3BCC58B23

P2860

Q36458146-0BE353B0-A2ED-4572-BD38-DD2AEC845877

Q36458146-12E04200-F657-45C3-8136-FF2C4734214C

Q36458146-1676C71B-3E57-4755-AFCB-ECE61CDD7824

Q36458146-26DF4F45-45B1-4882-A49D-465DE90B5D3B

Q36458146-65D100A5-944E-426E-8B89-3256D36AD322

Q36458146-6E94B26D-17D6-4145-A006-231F99E85EA5

Q36458146-76359D09-B2BB-4311-B0CF-BA673B5C9477

Q36458146-8943FB66-7CC8-4F8E-9A10-EF358089E9C9

Q36458146-8C5E3494-A301-4038-B463-D6CFF89DDCAE

Q36458146-E448710B-6412-4016-9F1A-ABC35705F115

P304

Q36458146-6CF83228-25C0-4A61-8FF6-A499F4B857FE

P31

Q36458146-996CE5D1-C14E-4F9F-92B8-F4F99E313E76

P356

Q36458146-7C79D198-A2E8-46D2-86DF-89229D9D70D3

P407

Q36458146-DE36910D-CB3C-41FA-B52F-BA914EC6DE0C

P433

Q36458146-A9A99347-B863-4E9C-80AD-F62B84429D72

P478

Q36458146-F74CE65C-637E-4004-881B-B4C40A1555AF

P577

Q36458146-E867135F-B558-4B0C-AC3C-0EC42121F9F5

P5875

Q36458146-A54B22ED-AFE4-4C45-B9F9-A8E94D047E75

P698

Q36458146-E1B77282-C1AA-4D7A-AB4C-1CF34DA9B9CA

P932

Q36458146-1EF65D83-4EA9-4754-A961-A565481F1423

P356

P1433

Journal of the National Cancer Institute

P1476

Preoperative nomogram predicti ...... ce after radical prostatectomy

@en

P2093

Andrew J Stephenson

http://www.w3.org/2001/XMLSchema#string

Fernando J Bianco

http://www.w3.org/2001/XMLSchema#string

James A Eastham

http://www.w3.org/2001/XMLSchema#string

Michael W Kattan

http://www.w3.org/2001/XMLSchema#string

Paul A Fearn

http://www.w3.org/2001/XMLSchema#string

Peter T Scardino

http://www.w3.org/2001/XMLSchema#string

Zohar A Dotan

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of progression after PSA elevation following radical prostatectomy.

Evaluating the yield of medical tests.

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).

Radical prostatectomy nomograms in black American men: accuracy and applicability.

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

P304

715-717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ190

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7076768

http://www.w3.org/2001/XMLSchema#string

P698

16705126

http://www.w3.org/2001/XMLSchema#string

P932

2242430

http://www.w3.org/2001/XMLSchema#string